|Year : 2017 | Volume
| Issue : 1 | Page : 76-81
Prevalence of human papillomavirus16 DNA and p16INK4a protein in oral squamous cell carcinoma: A systematic review and meta-analysis
T Smitha1, CV Mohan2, S Hemavathy3
1 Department of Oral Pathology, VS Dental College and Hospital, Bengaluru, Karnataka, India
2 Dental Care and Research Centre, Bengaluru, Karnataka, India
3 Department of Oral Pathology, Sri Rajiv Gandhi College of Dental Science, Bengaluru, Karnataka, India
|Date of Submission||29-Dec-2016|
|Date of Acceptance||11-Jan-2017|
|Date of Web Publication||5-Apr-2017|
Department of Oral Pathology, VS Dental College and Hospital, Bengaluru - - 560 004, Karnataka
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Background and Aim: Indian patients with oral squamous cell carcinoma (OSCC) are etiologically associated with the use of tobacco and alcohol; yet, a proportion of tumors that may harbor human papillomavirus (HPV) infections cannot be neglected. The following meta-analysis was conducted to address the association of p16INK4a and HPV DNA with OSCC. In addition, the study also provides the updated prevalence of HPV-induced OSCC.
Materials and Methods: Literature survey was performed using databases such as PubMed with the help of the following keywords – “HPV infection,” “oral squamous cell carcinoma,” “p16INK4a,” “HPV DNA,” “E6,” “E7,” “L1,” “L2” and “LCR.” Proportion method was performed to derive the forest plot using MedCalc statistical software version 16.4.3.
Results: Among 145 research articles, 33 articles were selected for further analysis, in which 13 articles were related to HPV DNA detection in tissues, 11 articles detected the overexpression of p16INK4a and nine articles reported the detection of both HPV DNA and p16INK4a expression. Meta-analysis revealed significant heterogeneity (P < 0.0001) among the articles. Overall, the study consisted of 3339 patients with OSCC, among which 559 patients were diagnosed with the presence of HPV16 DNA with a random proportion of 20.1% at 95% confidence interval (CI) (13.9–27.1, P < 0.0001). Overexpression of p16INK4a protein was observed in 709 patients with a random proportion of 25.4% at 95% CI (14.3–38.3, P < 0.0001).
Conclusion: HPV DNA and expression of p16INK4a was suggested as gold standard for the detection of HPV infection in many cases of cancers. Frequency of HPV infection is significantly higher in patients with OSCC as identified through the detection of HPV DNA and p16INK4a expression. Even though the association of HPV infection has been established in head and neck cancer, this review could further the establishment of molecular level interaction of HPV in patients with oral cancer.
Keywords: Human papillomavirus DNA, meta-analysis, oral squamous cell carcinoma, p16INK4a, random effect
|How to cite this article:|
Smitha T, Mohan C V, Hemavathy S. Prevalence of human papillomavirus16 DNA and p16INK4a protein in oral squamous cell carcinoma: A systematic review and meta-analysis. J Oral Maxillofac Pathol 2017;21:76-81
|How to cite this URL:|
Smitha T, Mohan C V, Hemavathy S. Prevalence of human papillomavirus16 DNA and p16INK4a protein in oral squamous cell carcinoma: A systematic review and meta-analysis. J Oral Maxillofac Pathol [serial online] 2017 [cited 2020 Jul 15];21:76-81. Available from: http://www.jomfp.in/text.asp?2017/21/1/76/203780
| Introduction|| |
Oral cancer is the sixth most common form of cancer in the world. The incidence varies because of geographic location, methods of detection and ethnicity. However, a higher incidence of the cancer is observed in the Southeast Asian region due to excessive use of tobacco. The ratio of men to women population prone to oral cancer in India has been reported to be 2:1. Apart from the use of tobacco, the prevalence of human papillomavirus (HPV) 16 has been reported in premalignant lesions and cancerous cells, predominantly in the cases of OSCC., In the Indian scenario, approximately, 45% of cancer cases are diagnosed as oral cancer, among which 20%–50% of the cases are observed to be associated with HPV infection., Apart from geographic location, the incidence of HPV-induced OSCC also varies with the genotype of virus.
Oral squamous cell carcinoma (OSCC) is one of the most common forms of malignant neoplasms of oral cavity. It affects the epithelial cells of oral and pharyngeal area. The etiological factors of OSCC include tobacco chewing, consumption of alcohol and infections by human papillomavirus (HPV) and hepatitis C virus, among others. In addition, disorders such as actinic cheilitis, erythroplakia, dyskeratosiscongenita and sideropenic dysphagia can also progress to OSCC.
HPV is a nonenveloped, double-stranded DNA virus of Papillomaviridae family. The circular double-stranded DNA is approximately 8000 base pairs in length and has early, late and noncoding genes. The early genes, E1, E2, E3, E4, E5, E6 and E7, are responsible for the control of viral transcription, replication and cellular transformation. L1 and L2 are the late genes involved in encoding proteins required for the formation of the capsid. The replication of virus and the transcription of early genes are regulated by a noncoding long control region (LCR) gene. Based on the genotypic differences, especially in the gene region of E6 and E7, HPV is differentiated into high- and low-risk types.
HPV16 has been recognized as an etiological factor for OSCC by the International Agency for Research against Cancer. Globally, HPV infection is a sexually transmitted disease; however, it can also be transmitted to the infants through the placenta. Areas of the mouth, tonsils, oropharynx, vagina and vulva are among the primary sites of the infection. In HPV-induced carcinoma, the viral genome gets integrated in the host cell genome leading to a break in E1 and E2 regions. This results in the loss of control for the synthesis of E6 and E7 proteins, which in turn inhibits the functions of tumor suppressor genes including p53 and retinoblastoma protein (pRB). Binding of E7 protein with pRB causes its inactivation, consequently enhancing the expression of p16INK4a. The overexpression of p16INK4a further prevents the activation of pRB. The detection of overexpressed p16INK4a has thus been researched for the early diagnosis of HPV-induced OSCC along with other molecular typing methods such as immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR). On the other hand, the protein encoded by E6 also hinders apoptosis of the cells by interfering with the activity of proteins such as Bak and procaspase, leading to the development of OSCC.,
The following meta-analysis was conducted to address the association of p16INK4a and HPV DNA with oral carcinoma. In addition, the study also provides the updated prevalence of HPV-induced OSCC.
| Materials and Methods|| |
Sources of data
Literature search was performed using databases such as PubMed (maintained by the United States National Library of Medicine) to collect the related studies published from 1995 to 2016. The keywords used for the search included “HPV infection,” “Oral squamous cell carcinoma” p16INK4a, “HPV DNA,” early genes “E6” and “E7,” late gene “L1,” “L2” and noncoding control “LCR.”
English articles involving studies on fresh and frozen or formalin-fixed, paraffin-embedded (FFPE) tissue samples and articles retrieved after a particular search were included in the analysis. Articles having studies on cell lines, biofluids, head and neck cancer, polymorphism, methylation, healthy control and microRNA were excluded from the analysis. Review and meta-analysis articles, along with those in other languages than English, were also excluded from the analysis.
Proportion method was performed, and forest plot was derived to carry out meta-analysis by using MedCalc software version 16.4.3 (Ostend, Belgium). The proportion of HPV DNA and p16INK4a in OSCC cases was analyzed at 95% confidence interval (CI). Random effects model (DerSimonian and Laird method) was used in the analysis due to the presence of significant heterogeneity.
| Results|| |
The study included 145 research articles, out of which 112 articles were excluded. The excluded articles include the articles, which were in other languages (n = 6), either review articles or meta-analysis (n = 16), related to cell line study (n = 14), biofluids (n = 6), head and neck cancer (n = 2) and articles related to polymorphism, methylation, healthy control or microRNA (n = 68). Among the 33 research articles included in the analysis, 9 articles conducted the study with the help of fresh tissue sample whereas 24 articles conducted the study with the help of frozen or FFPE tissue samples.
Of the 33 research articles, 28 articles were found to be related with the study of HPV DNA in OSCC cases. There was significant heterogeneity (P < 0.0001) in the studies (I2 = 94.68% with 93.27–95.79 CI at 95%). These studies included 3083 patients, among which 559 patients were reported to be positive for HPV DNA. Proportion of positive cases for HPV16 was analyzed in the present meta-analysis. The average proportion of positive cases was found to be 18.11%. However, the studies done by Tania et al. (2015) and Chen et al. did not find any positive case with 0.00–2.91 and 0.00–8.81 CI at 95%, respectively. On the other hand, Nemes et al. (2016) found a high proportion of 81.82% with 64.54–93.02 CI at 95%. However, Rietbergen et al. (2014) included the highest number of patients in the study [Figure 1].
|Figure 1: Forest plot of human papillomavirus 16 DNA in oral squamous cell carcinoma samples|
Click here to view
Among the 33 articles, twenty research articles were related with p16INK4a. There was significant heterogeneity (P < 0.0001) in the selected studies (I2 = 98.07% with 97.64–98.42 CI at 95%). These studies included 2578 patients, among which 709 patients were reported to be positive for HPV DNA. Proportion of positive cases for p16INK4a was determined by following the random effect analysis. A study conducted by Singh et al. had a low proportion of 3.6% with 1.65–6.72 CI at 95% whereas a study by Gröbe et al. had a high proportion of 89.64% with 84.86–93.32 CI at 95%. Out of the twenty research articles, 13 were found to have proportion between 0% and 25% [Figure 2]. However, nine research articles were found to be associated with the study of both HPV DNA and p16 expression [Figure 3].
|Figure 2: Forest plot of p16INK4a immunohistochemistry in oral squamous cell carcinoma samples|
Click here to view
| Discussion|| |
The comprehensive meta-analysis of research articles in the present study included 3339 patients diagnosed with OSCC. Among them, 559 patients were positively diagnosed with the presence of HPV16 DNA with a random proportion of 20.1% at 95% CI (13.9–27.1, P < 0.0001) and 709 patients were found to have the overexpression of p16INK4a protein with a random proportion of 25.4% at 95% CI (14.3–38.3, P < 0.0001). The meta-analysis was performed to determine the prevalence of HPV DNA and p16 in OSCC.
Major etiological factors for the development of oral lesions and OSCC include alcohol and tobacco consumption along with the presence of HPV infection in the diagnosed individual. The lesions may develop because of a single factor or due to synergistic effect of multiple factors. Singh et al. reported the prevalence of HPV infection in patients with OSCC involved in the consumption of tobacco and betel leaves. They also revealed that the concordance of HPV-induced OSCC is significantly more in men than in women (P = 0.02). Similarly, another Indian study by Balaram et al. reported the concordance of HPV16 and 18 in 42% and 47% of the patients, respectively, suggesting viral infection as an vital etiological factor along with the consumption of betel leaves. The use of betel levels, as hypothesized, may lead to the synergistic mutagenic effect in the development of OSCC. A study conducted by Gan et al. in Chinese population reported the prevalence of combined infection in the development of cancerous lesion in the oral region, due to the presence of HPV16/18 along with traditional factors (tobacco and alcohol). They found that patients with preexisting HPV infection and history of tobacco and alcohol consumption have a high risk of developing cancer in the oral region. The odds ratio of the factors was found to be 13.3 with 95% CI of 3.1–56.8. However, González-Ramírez et al. conducted a study on eighty Mexican patients diagnosed with OSCC and found that high-risk-HPV was a controlling factor in the occurrence of oral cancer at a young age, i.e., <45 years even without the traditional risk factors of alcohol and tobacco consumption. Similar conclusion was obtained by another study by Ibieta et al., in which no significant difference was observed in the HPV-positive and HPV-negative controls, with respect to smoking and drinking as the cofactors. A study on 124 patients with oral cancer by Kane et al. also demonstrated the prevalence of HPV-induced OSCC in 31.3% of patients without the history of tobacco use. In addition, HPV infection being one of the sexually transmitted diseases, significant multiplicative interaction (P < 0.001) was found between HPV16/18 and age at the first intercourse in a study by Chen et al. for the development of OSCC.
Molecular and immune-staining techniques have been used in the detection of HPV infection in patients with OSCC. The presence of the DNA is usually detected by performing DNA extraction and PCR from frozen or FFPE tissue samples. However, the genotyping of the virus is detected by the use of specific primers in quantitative PCR (qPCR), southern hybridization or by in situ hybridization. Chaudhary et al. applied hybrid capture-II assay and PCR for the detection of HPV DNA in 222 patients with OSCC. The comparison of the methods was done based on their specificity and sensitivity. They concluded that the hybrid capture-II assay was more sensitive in the diagnosis of HPV-induced OSCC when compared with PCR. The detection of HPV DNA is usually done to detect the regions of L1, E6 and/or E7, as these are the genes present in the genome of the virus primarily involved in the process leading to the development of cancerous cells. Chen et al. and Palve et al. detected the presence of E6 transcript by SYBR Green-based qPCR assay. On the other hand, the transcripts E6/E7 were detected by consensus PCR in the study conducted by Shima et al.
p16INK4a has long been considered as a biomarker in the identification of head and neck cancer along with cancer in dysplastic cervical epithelia., The integration of viral genome in the host and the splitting of its genome in between the E1 and E2 regions lead to the loss of control in the expression of E7. This protein in turn deactivates pRB protein, leading to the overexpression of p16INK4a. Its detection, therefore, confirms the inhibition of host cell apoptosis, leading to the conversion of normal cells into cancerous cells. The integration also leads to the production of mRNA of the p16 protein, which can also be used in the detection of cancer. In addition, inhibition of pRB and overexpression of p16INK4a protein also, to some extent, confirm the role of HPV and therefore make it an essential etiological factor in the development of cancer.
qPCR has been used for the detection of oncogenic mRNA (mRNA of E6 and E7) and DNA., Several studies have been performed to correlate the expression of mRNA with the prevalence of HPV infection in cancer cases. A study conducted by Olthof et al. in HPV genome was found to integrate itself in between the human genes such as Fanconi Anemia Complementation Group C and Histone Deacetylase 2, which play a role in head and neck cancer. In addition, RNA in situ hybridization was found to be more sensitive than DNA hybridization. Thus, mRNA profiling can be performed along with the detection of DNA for early and confirmatory detection of HPV infection., However, its use as a biomarker in the diagnosis of OSCC is contradictory due to its instability as compared to DNA and protein. RNA can also be silenced by host defense mechanism and hence may not lead to the development of cancer. Therefore, p16INK4a can be assessed for confirming the role of HPV in cancer as overexpression of p16INK4a is due to the activity of proteins produced from HPV mRNA.
Sritippho et al. (2015) reported the expression of p16 in 21.6% of the patients with OSCC. They also reported a significant association (P < 0.05) between HPV DNA and p16 with odds ratio of 20 at 95% CI (1.9–211.8). It was observed that detection of p16 overexpression demonstrated 40% sensitivity and 79.3% specificity, hence p16 can be used in the detection of HPV infection rather than as a marker for HPV-induced OSCC identification. Its role as a biomarker in detecting OSCC has been supported by a study reported by Agarwal et al. (2013). They found that 22.5% of patients with OSCC were positive for HPV16. Among these patients, 85.17% of the cells were found to be positive for p16. Prakash et al. also reported the overexpression of p16 in several cases (71%) of patients with OSCC. Similar study conducted by Gröbe et al. concluded that p16 overexpression can be considered as a useful diagnostic biomarker for the detection of HPV infection. It has been also found in some studies that the HPV DNA and p16INK4a overexpression is localized in the region of cancerous lesion and is observed to decrease beyond the focal point. The immunohistochemical staining is often used to detect the expression of protein, which is further evaluated based on intensity, localization, distribution and proportion of the stain in the tumor cells. The tissue samples exhibiting more than 70% p16INK4a expression in the tumor cells, with diffuse staining in cytoplasmic and nuclear region, are considered as tumor of the laryngeal region.
| Conclusion|| |
The above meta-analysis of HPV infection, identified through the presence of HPV16 DNA and p16INK4a expression, implies that the frequency of HPV infection is significantly higher in patients with OSCC. Association of HPV infection as a causative factor in cervical and in a subset of oropharyngeal squamous cell carcinomas is highly established; however, there is a paucity in the published data to reveal the association as of HPV infection as causative factor in OSCC. This review may open up further research to establish the molecular level interaction of HPV in patients with OSCC, and early identification of disease status may serve in future therapeutic implications to reduce the disease burden for the betterment of patient care.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Salian V, Dinakar C, Shetty P, Ajila V. Etiological trends in oral squamous cell carcinoma: A retrospective institutional study. Cancer Transl Med 2016;2:33. [Full text]
Chocolatewala NM, Chaturvedi P. Role of human papilloma virus in the oral carcinogenesis: An Indian perspective. J Cancer Res Ther 2009;5:71-7.
Khangura RK, Sengupta S, Sircar K, Sharma B, Singh S, Rastogi V. HPV involvement in OSCC: Correlation of PCR results with light microscopic features. J Oral Maxillofac Pathol 2013;17:195-200.
] [Full text]
Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J 2012;6:126-30.
Gupta S, Gupta S. Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature. Indian J Dent 2015;6:91-8.
] [Full text]
World Health Organization, International Agency for Research on Cancer. Human Papillomaviruses. Geneva, Switzerland: World Health Organization; 2007.
Agrawal GP, Joshi PS, Agrawal A. Role of HPV-16 in pathogenesis of oral epithelial dysplasia and oral squamous cell carcinoma and correlation of p16INK4a
expression in HPV-16 positive cases: An immunohistochemical study. ISRN Pathol 2013;2013:1-7.
Singh V, Husain N, Akhtar N, Kumar V, Tewari S, Mishra S, et al.
Do human papilloma viruses play any role in oral squamous cell carcinoma in North Indians? Asian Pac J Cancer Prev 2015;16:7077-84.
Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, et al.
Human papillomaviruses in 91 oral cancers from Indian betel quid chewers – High prevalence and multiplicity of infections. Int J Cancer 1995;61:450-4.
Gan LL, Zhang H, Guo JH, Fan MW. Prevalence of human papillomavirus infection in oral squamous cell carcinoma: A case-control study in Wuhan, China. Asian Pac J Cancer Prev 2014;15:5861-5.
González-Ramírez I, Irigoyen-Camacho ME, Ramírez-Amador V, Lizano-Soberón M, Carrillo-García A, García-Carrancá A, et al.
Association between age and high-risk human papilloma virus in Mexican oral cancer patients. Oral Dis 2013;19:796-804.
Ibieta BR, Lizano M, Fras-Mendivil M, Barrera JL, Carrillo A, Ma Ruz-Godoy L, et al.
Human papilloma virus in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:311-5.
Kane S, Patil VM, Noronha V, Joshi A, Dhumal S, D'Cruz A, et al.
Predictivity of human papillomavirus positivity in advanced oral cancer. Indian J Cancer 2015;52:403-5.
] [Full text]
Chen F, Yan L, Liu F, Huang J, Liu F, Wu J, et al.
Oral human papillomavirus infection, sexual behaviors and risk of oral squamous cell carcinoma in Southeast of China: A case-control study. J Clin Virol 2016;85:7-12.
Kouketsu A, Sato I, Abe S, Oikawa M, Shimizu Y, Takahashi T, et al.
Detection of human papillomavirus infection in oral squamous cell carcinoma: A cohort study of Japanese patients. J Oral Pathol Med 2016;45:565-72.
Chaudhary AK, Pandya S, Mehrotra R, Bharti AC, Singh M, Singh M. Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J 2010;7:253.
Chen XJ, Sun K, Jiang WW. Absence of high-risk HPV 16 and 18 in Chinese patients with oral squamous cell carcinoma and oral potentially malignant disorders. Virol J 2016;13:81.
Palve V, Bagwan J, Krishnan NM, Pareek M, Chandola U, Suresh A, et al
. High-risk human papillomavirus in oral cavity squamous cell carcinoma. BioRxiv 082651; [doi: https://doi.org/10.1101/082651
Shima K, Kobayashi I, Saito I, Kiyoshima T, Matsuo K, Ozeki S, et al.
Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan. Br J Oral Maxillofac Surg 2000;38:445-50.
El-Mofty SK. Histopathologic risk factors in oral and oropharyngeal squamous cell carcinoma variants: An update with special reference to HPV-related carcinomas. Med Oral Patol Oral Cir Bucal 2014;19:e377-85.
Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al.
immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
Cuschieri K, Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2008;17:2536-45.
Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, et al.
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2013;49:1-8.
Tsimplaki E, Argyri E, Xesfyngi D, Daskalopoulou D, Stravopodis DJ, Panotopoulou E. Prevalence and expression of human papillomavirus in 53 patients with oral tongue squamous cell carcinoma. Anticancer Res 2014;34:1021-5.
Olthof NC, Speel EJ, Kolligs J, Haesevoets A, Henfling M, Ramaekers FC, et al.
Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS One 2014;9:e88718.
Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr. High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ
hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol 2011;35:1343-50.
Wang H, Sun R, Lin H, Hu WH. P16INK4A
as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: Consideration of some aspects. Cancer Sci 2013;104:1553-9.
Sritippho T, Chotjumlong P, Iamaroon A. Roles of human papillomaviruses and p16 in oral cancer. Asian Pac J Cancer Prev 2015;16:6193-200.
Prakash P, Khandare M, Kumar M, Khanna R, Singh GP, Nath G, et al.
Immunohistochemical detection of p16(INK4a)
in leukoplakia and oral squamous cell carcinoma. J Clin Diagn Res 2013;7:2793-5.
Gröbe A, Hanken H, Kluwe L, Schöllchen M, Tribius S, Pohlenz P, et al.
Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma. J Oral Pathol Med 2013;42:676-81.
Hernandez BY, Rahman M, Lynch CF, Cozen W, Unger ER, Steinau M, et al.
) expression in invasive laryngeal cancer. Papillomavirus Res 2016;2:52-5.
[Figure 1], [Figure 2], [Figure 3]